Keith has recently updated the chapter in Barnett’s GCP Q&A Reference Guide on Risk-Based Quality Management and Quality by Design. 
Keith also has an extensive blog on topics from risk management to issues and measurement.
Articles written/contributed to:
- “Launching the mindsON RBQM Expert Working Group on RBQM”, DIA Global Forum, October 2025
- “Defining QTLs and KRIs that Detect Risks in a Timely Manner: Reflections from Early Adopters on Emerging Practices”, Applied Clinical Trials, April 2022
- “Measure the Right Things at the Right Time: Design Key Risk Indicators and Key Performance Indicators that Provide Timely Insights“, MCC White Paper
- “Establishing Meaningful Quality Metrics for Vendor Oversight“, Pharmaceutical Outsourcing, June 2020
- “Aligning Data Entry and Site Payment Incentives For Clinical Trials and Patients“, Applied Clinical Trials, September 2017
- “Importance of Data Entry Timeliness”, Applied Clinical Trials, April 2017
- “Using Metrics to Direct Performance Improvement Efforts in Clinical Trial Management”, ACRP Monitor Lead Article 2012